The functional silencing of SOX11 using CRISPR interference (dCas9-KRAB) inhibited cell growth and reduced tumor volume in NB, whereas the silencing of SOX4 confirmed its role in ATRA-induced differentiation. The gene discussed is SOX4; the disease is neuroblastoma.